Kenneth C Frazier is Executive Chair of Merck & Co., Inc.. Currently has a direct ownership of 700,653 shares of MRK, which is worth approximately $69.5 Million. The most recent transaction as insider was on Mar 13, 2019, when has been sold 18,725 shares (Common Stock) at a price of $39.29 per share, resulting in proceeds of $735,705. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 701K
0% 3M change
0% 12M change
Total Value Held $69.5 Million

KENNETH C FRAZIER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2019
BUY
Exercise of conversion of derivative security
$735,705 $39.29 p/Share
18,725 Added 2.24%
816,440 Common Stock
Mar 05 2019
SELL
Open market or private sale
$570,802 $82.0 p/Share
6,961 Reduced 0.87%
797,715 Common Stock
Mar 05 2019
BUY
Exercise of conversion of derivative security
$273,498 $39.29 p/Share
6,961 Added 0.86%
804,676 Common Stock
Mar 04 2019
SELL
Open market or private sale
$1,077,939 $82.01 p/Share
13,144 Reduced 1.62%
797,715 Common Stock
Mar 04 2019
BUY
Exercise of conversion of derivative security
$516,428 $39.29 p/Share
13,144 Added 1.6%
810,859 Common Stock
Feb 25 2019
BUY
Grant, award, or other acquisition
$8,501,390 $80.38 p/Share
105,765 Added 11.71%
797,715 Common Stock
Feb 22 2019
SELL
Open market or private sale
$4,317,959 $80.02 p/Share
53,961 Reduced 7.23%
691,950 Common Stock
Feb 22 2019
BUY
Exercise of conversion of derivative security
$2,120,128 $39.29 p/Share
53,961 Added 6.75%
745,911 Common Stock
Feb 21 2019
SELL
Open market or private sale
$3,359,360 $80.0 p/Share
41,992 Reduced 5.72%
691,950 Common Stock
Feb 21 2019
BUY
Exercise of conversion of derivative security
$1,649,866 $39.29 p/Share
41,992 Added 5.41%
733,942 Common Stock
Feb 19 2019
SELL
Open market or private sale
$3,416,854 $80.02 p/Share
42,700 Reduced 5.81%
691,950 Common Stock
Feb 19 2019
BUY
Exercise of conversion of derivative security
$1,677,683 $39.29 p/Share
42,700 Added 5.49%
734,650 Common Stock
Feb 15 2019
SELL
Open market or private sale
$7,435,827 $80.03 p/Share
92,913 Reduced 11.84%
691,950 Common Stock
Feb 15 2019
BUY
Exercise of conversion of derivative security
$3,650,552 $39.29 p/Share
92,913 Added 10.59%
784,863 Common Stock
Feb 05 2019
SELL
Open market or private sale
$18,080,674 $78.08 p/Share
231,566 Reduced 25.07%
691,950 Common Stock
Feb 05 2019
BUY
Exercise of conversion of derivative security
$9,098,228 $39.29 p/Share
231,566 Added 20.05%
923,516 Common Stock
Oct 02 2018
SELL
Open market or private sale
$20,168,789 $72.07 p/Share
279,850 Reduced 28.8%
691,950 Common Stock
Oct 02 2018
BUY
Exercise of conversion of derivative security
$10,231,316 $36.56 p/Share
279,850 Added 22.36%
971,800 Common Stock
Sep 18 2018
SELL
Open market or private sale
$19,611,959 $70.08 p/Share
279,851 Reduced 28.8%
691,950 Common Stock
Sep 18 2018
BUY
Exercise of conversion of derivative security
$10,231,353 $36.56 p/Share
279,851 Added 22.36%
971,801 Common Stock
Jul 31 2018
SELL
Open market or private sale
$14,825,915 $65.0 p/Share
228,091 Reduced 24.3%
710,697 Common Stock
Jul 31 2018
SELL
Bona fide gift
-
18,747 Reduced 2.64%
691,950 Common Stock
Jul 31 2018
BUY
Exercise of conversion of derivative security
$7,638,768 $33.49 p/Share
228,091 Added 19.55%
938,788 Common Stock
Feb 27 2018
BUY
Grant, award, or other acquisition
$6,040,705 $54.72 p/Share
110,393 Added 13.44%
710,697 Common Stock
Feb 27 2017
BUY
Grant, award, or other acquisition
$6,687,199 $65.85 p/Share
101,552 Added 14.47%
600,304 Common Stock

Also insider at

XOM
EXXON MOBIL CORP Energy
KCF

Kenneth C Frazier

Executive Chair
Irving, TX

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Track Activities on MRK